SCHEMBL5775890

SCHEMBL5775890

COC[C@@H](N)Cc1nc2ccccc2o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.51
MAPT P10636 4/20 0.51
RAB9A P51151 3/20 0.51
LOXL2 Q9Y4K0 1/20 0.50
TP53 P04637 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.44
GFER P55789 1/20 0.44
USP2 O75604 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ELANE P08246 1/20 0.38
DDAH1 O94760 1/20 0.37
ADRA2C P18825 1/20 0.37
KMT2A Q03164 2/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA10 Q9GZZ6 1/20 0.36
CHRNA9 Q9UGM1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635001 0.83 NPC1 (0.56) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL6630027 0.81 RAB9A (0.53) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL16486847 0.80 NPC1 (0.56) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL8298679 0.76 NPC1 (0.47) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL6505533 0.76 NPC1 (0.47) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL14584995 0.76 NPC1 (0.63) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL5535419 0.76 MAPT (0.63) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL6632718 0.75 MAPT (0.54) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL30714783 0.72 RAB9A (0.46) NPC1MAPTRAB9ALOXL2TP53
SCHEMBL5288034 0.72 NPC1 (0.53) NPC1MAPTRAB9ALOXL2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682524-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2006-07-26 EP disclosed
WO-2005040142-A9 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMA INC (US) 2005-06-09 WO disclosed
WO-2005040142-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2005-05-06 WO disclosed